Arkolith/Insider Trading/MRNS/Form 4

Pfanstiel Steven

CFO AND COOMARINUS PHARMACEUTICALS, INC. (MRNS) · full profile →Form 4 · filed Feb 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2025Disposed to issuer(D)62K$0.55$34K0
Feb 7, 2025Disposed to issuer(D)17K$0.55$10K62K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2025Disposed to issuer(D)220K—$00
Feb 11, 2025Disposed to issuer(D)74K—$00
Feb 11, 2025Disposed to issuer(D)127K—$00
Feb 11, 2025Disposed to issuer(D)115K—$00
Feb 11, 2025Disposed to issuer(D)57K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-011241) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML